Rigel Pharmaceuticals Inc (RIGL) — Financial Flexibility Index
Rigel Pharmaceuticals Inc (RIGL) has a Financial Flexibility Index of 0.03x as of March 2026. Free cash flow of $2.73 Million (operating CF $2.73 Million minus capex $0.00) represents 0% of total liabilities ($104.71 Million). Check how strategically is Rigel Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rigel Pharmaceuticals Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Rigel Pharmaceuticals Inc across 27 annual periods. See working capital position of Rigel Pharmaceuticals Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Rigel Pharmaceuticals Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Rigel Pharmaceuticals Inc. For the full company profile including market capitalisation, see Rigel Pharmaceuticals Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | $75.66 Million | $75.66 Million | $122.11 Million | ▲ +212.4% |
| 2024 | 0.20x | $31.87 Million | $31.47 Million | $160.69 Million | ▲ +212.5% |
| 2023 | 0.06x | $9.26 Million | $-5.74 Million | $145.87 Million | ▲ +112.8% |
| 2022 | -0.50x | $-73.31 Million | $-73.76 Million | $147.90 Million | ▼ -1143.6% |
| 2021 | 0.05x | $6.50 Million | $5.88 Million | $136.95 Million | ▲ +107.1% |
| 2020 | -0.67x | $-50.92 Million | $-52.19 Million | $76.35 Million | ▼ -56.1% |
| 2019 | -0.43x | $-40.05 Million | $-41.51 Million | $93.75 Million | ▲ +78.4% |
| 2018 | -1.97x | $-57.72 Million | $-58.83 Million | $29.23 Million | ▲ +52.9% |
| 2017 | -4.19x | $-77.39 Million | $-77.56 Million | $18.46 Million | ▼ -29.0% |
| 2016 | -3.25x | $-75.08 Million | $-75.89 Million | $23.11 Million | ▼ -473.6% |
| 2015 | -0.57x | $-22.87 Million | $-23.41 Million | $40.37 Million | ▲ +78.8% |
| 2014 | -2.68x | $-69.34 Million | $-69.75 Million | $25.89 Million | ▲ +43.8% |
| 2013 | -4.76x | $-84.84 Million | $-86.06 Million | $17.81 Million | ▼ -22.0% |
| 2012 | -3.91x | $-81.81 Million | $-85.19 Million | $20.95 Million | ▼ -22.0% |
| 2011 | -3.20x | $-67.07 Million | $-69.38 Million | $20.96 Million | ▼ -230.8% |
| 2010 | 2.45x | $50.30 Million | $46.74 Million | $20.56 Million | ▲ +173.6% |
| 2009 | -3.32x | $-102.64 Million | $-102.78 Million | $30.88 Million | ▼ -30.6% |
| 2008 | -2.54x | $-101.01 Million | $-103.52 Million | $39.69 Million | ▼ -66.8% |
| 2007 | -1.53x | $-51.27 Million | $-52.21 Million | $33.61 Million | ▼ -13.6% |
| 2006 | -1.34x | $-34.92 Million | $-35.84 Million | $26.01 Million | ▼ -57.2% |
| 2005 | -0.85x | $-33.38 Million | $-35.17 Million | $39.08 Million | ▲ +38.1% |
| 2004 | -1.38x | $-36.61 Million | $-38.15 Million | $26.52 Million | ▲ +31.2% |
| 2003 | -2.01x | $-31.20 Million | $-32.44 Million | $15.55 Million | ▼ -15.3% |
| 2002 | -1.74x | $-32.89 Million | $-34.53 Million | $18.90 Million | ▼ -138.9% |
| 2001 | -0.73x | $-12.75 Million | $-15.98 Million | $17.51 Million | ▼ -39.4% |
| 2000 | -0.52x | $-7.97 Million | $-11.59 Million | $15.25 Million | ▼ -1051.4% |
| 1999 | -0.05x | $-745.00K | $-7.83 Million | $16.41 Million | — |